Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry
Uppsala Univ, Sweden.
Skane Univ Hosp, Sweden.
Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Haematology.
Sahlgrens Univ Hosp, Sweden.
Show others and affiliations
2019 (English)In: European Journal of Haematology, ISSN 0902-4441, E-ISSN 1600-0609, Vol. 103, no 2, p. 88-98Article in journal (Refereed) Published
Abstract [en]

Objectives As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results of clinical trials need to relate to standard of care. Methods We used the population-based Swedish ALL Registry to evaluate characteristics, treatment and long-term outcome in 933 patients with diagnosis between 1997 and 2015. Results The median age was 53 years. The frequency of Philadelphia (Ph)-positive leukaemia was 34% of examined B-ALL with a peak incidence at 50-59 years. Five-year overall survival (OS) improved between 1997-2006 and 2007-2015; in patients 18-45 years from 50% (95% CI 43-57) to 65% (95% CI 58-72), 46-65 years from 25% (95% CI 18-32) to 46% (95% CI 37-55) and amp;gt;65 years from 7% (95% CI 2.6-11) to 11% (95% CI 5.9-16) (P amp;lt; 0.05). Men with Ph-neg B-ALL 46-65 years had inferior OS compared with women (P amp;lt; 0.01). Standardised mortality ratio was 5.7 (95% CI 5.0-6.3) for patients who survived 5 years from diagnosis. In multivariable analysis, Ph-positive disease was not associated with impaired prognosis but with lower risk of death in 2007-2015. Conclusions In a population-based cohort, OS has improved in adult ALL, especially for Ph-positive disease but for middle-aged men with Ph-negative B-ALL outcome was poor. Cure without late toxicity or relapse is still desired.

Place, publisher, year, edition, pages
WILEY , 2019. Vol. 103, no 2, p. 88-98
Keywords [en]
acute lymphoblastic leukaemia; adult; Philadelphia-positive
National Category
Hematology
Identifiers
URN: urn:nbn:se:liu:diva-159124DOI: 10.1111/ejh.13247ISI: 000475475200003PubMedID: 31074910OAI: oai:DiVA.org:liu-159124DiVA, id: diva2:1339677
Note

Funding Agencies|Lions Cancer Foundation Uppsala; Uppsala University; Uppsala County Council/Region agreement on medical training and clinical research (ALF)

Available from: 2019-07-30 Created: 2019-07-30 Last updated: 2019-11-14

Open Access in DiVA

fulltext(688 kB)6 downloads
File information
File name FULLTEXT01.pdfFile size 688 kBChecksum SHA-512
f3645ab9e0c185e21dfa51f28261a3fb91369982a2f13b08645139319d5e52f0a2ec6e723d9e3143c54c8dd17d9e85fd9669c082bb8027e6ce9aa586fa56b4c2
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ahlberg, Lucia
By organisation
Department of Haematology
In the same journal
European Journal of Haematology
Hematology

Search outside of DiVA

GoogleGoogle Scholar
Total: 6 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 22 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf